Ankur Drugs & Pharma Ltd.
| BSE: 531683 | Sector: Health care |
| NSE: ANKURDRUGS | ISIN Code: INE238D01012 |
| BSE 05:30 | 01 Jan | Ankur Drugs & Pharma Ltd |
| NSE 05:30 | 01 Jan | Ankur Drugs & Pharma Ltd |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Ankur Drugs & Pharma Ltd. (ANKURDRUGS) - Financial Ratios
| Ratios | 2012 | 2011 | 2010 |
| Debt-Equity Ratio | 3.82 | 3.26 | 2.70 |
| Current Ratio | 0.17 | 0.30 | 0.65 |
| Asset turnover ratio | 0.11 | 0.78 | 1.84 |
| Inventory turnover ratio | 1.66 | 3.89 | 4.52 |
| Debtors turnover ratio | 4.36 | 17.81 | 6.37 |
| Interest Coverage ratio | -1.47 | 0.61 | 2.49 |
| Operating Margin (%) | -16.14 | 16.27 | 21.24 |
| Net Profit Margin (%) | -112.40 | -8.31 | 8.05 |
| Return on Capital Employed (%) | 0.00 | 5.42 | 17.58 |
| Return on Net Worth (%) | 0.00 | -21.31 | 27.41 |
Quick Links for Ankur Drugs & Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
